Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Olema Pharmaceuticals

Olema Pharmaceuticals
PRIVATE STATUS
Series A LATEST DEAL TYPE
$6.05M LATEST DEAL AMOUNT
Description

Owner and operator of a Biotechnology company intended to develop new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. The company's technology has used Pure Antagonist - Selective Estrogen Receptor Degraders (PA-SERDs) designed to both completely inactivate and degrade ER, oral PA-SERD that blocks estrogen-driven gene activity and proliferation, degrades the estrogen receptor in human breast cancer cells and CAR T therapy in treatment of lymphoma and leukemia, enabling patients to have better treatment opportunity for cancer, lymphoma and leukemia.

Formerly Known As
CombiThera
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Other Pharmaceuticals and Biotechnology
Primary Office
  • 665 3rd Street
  • Suite 250
  • San Francisco, CA 94107
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Olema Pharmaceuticals’s full profile, request a free trial.

Olema Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 23-Aug-2018 $6.05M 00.000 Completed Pre-Clinical Trials
To view this company’s complete deal history including valuation and funding, request access »

Olema Pharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
Cyrus Harmon Ph.D Founding Chief Executive Officer, President & Board Member
Peter Kushner Ph.D Chief Scientific Officer & Chairman

Olema Pharmaceuticals Board Members (8)

Name Representing Role Since Contact
Info
Andrei Manoliu Ph.D Olema Pharmaceuticals Board Member 000 0000
Andrew Rappaport Olema Pharmaceuticals Board Member 000 0000
Cyrus Harmon Ph.D Olema Pharmaceuticals Founding Chief Executive Officer, President & Board Member 000 0000
Frank McCormick Ph.D Self Board Member 000 0000
Gorjan Hrustanovic Olema Pharmaceuticals Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »